RELMADA THERAPEUTICS, INC. Accounts Payable
RELMADA THERAPEUTICS, INC. (RLMD) had Accounts Payable of $2.41 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $2.41M.
- 2026-03-31: Accounts Payable, Current $5.73M.
- 2025-12-31: Accounts Payable, Current $1.57M.
- 2025-09-30: Accounts Payable, Current $1.45M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $2.41M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $5.73M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.57M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.45M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.36M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.27M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $4.13M 10-K · filed 2026-03-19 |
| 2024-09-30 | $2.35M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $4.17M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $5.19M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.51M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.86M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.85M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.42M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.26M 10-K · filed 2024-03-19 |
| 2022-09-30 | $10.43M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $7.54M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $10.67M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $11.19M 10-K · filed 2023-03-23 |
| 2021-09-30 | $12.71M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $10.46M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $8.08M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $8.35M 10-K · filed 2022-03-25 |
| 2020-09-30 | $728.63K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $965.17K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.10M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $522.66K 10-K · filed 2021-03-24 |
| 2019-09-30 | $1.27M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $924.36K 10-K · filed 2021-03-24 |
| 2019-03-31 | $1.08M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $358.89K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $1.02M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $765.44K 10-KT · filed 2020-03-26 |
| 2018-03-31 | $1.09M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $286.06K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $350.54K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $529.56K 10-K · filed 2018-09-28 |
| 2017-03-31 | $335.43K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $307.24K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $671.72K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.26M 10-K · filed 2017-09-28 |
| 2016-03-31 | $744.16K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.69M 10-Q · filed 2016-02-05 |
| 2015-09-30 | $1.15M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $835.28K 10-K · filed 2016-09-09 |
| 2015-03-31 | $390.37K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $969.95K 10-Q · filed 2015-02-13 |
| 2014-09-30 | $624.73K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $746.10K 10-K · filed 2015-09-11 |
| 2014-03-31 | $127.09K 8-K · filed 2014-05-27 |
| 2014-02-28 | $41.16K 10-Q · filed 2014-04-15 |
| 2013-12-31 | $180.32K 10-KT · filed 2014-09-09 |
| 2013-11-30 | $40.33K 10-Q · filed 2014-01-13 |
| 2013-08-31 | $33.67K 10-Q · filed 2014-04-15 |
| 2013-05-31 | $25.75K 10-Q · filed 2013-07-12 |
| 2013-02-28 | $12.00K 10-Q · filed 2013-05-03 |
| 2012-12-31 | $237.42K 8-K · filed 2014-05-27 |
| 2012-08-31 | $7.00K 10-K · filed 2013-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |